SPX3,941.26-57.58 -1.44%
DIA336.46-3.57 -1.05%
IXIC11,014.89-225.05 -2.00%

Raymond James Maintains Strong Buy on Aveanna Healthcare Hldgs, Lowers Price Target to $4

Benzinga · 11/16/2022 07:20
Raymond James analyst John Ransom maintains Aveanna Healthcare Hldgs (NASDAQ:AVAH) with a Strong Buy and lowers the price target from $6 to $4.